AVEANNA HEALTHCARE ($AVAH) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of $0.18 per share, beating estimates of $0.13 by $0.05. The company also reported revenue of $647,920,000, beating estimates of $625,454,820 by $22,465,180.
You can see Quiver Quantitative's $AVAH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AVEANNA HEALTHCARE Insider Trading Activity
AVEANNA HEALTHCARE insiders have traded $AVAH stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $AVAH stock by insiders over the last 6 months:
- JEFF SHANER (Chief Executive Officer) has made 0 purchases and 6 sales selling 546,869 shares for an estimated $4,101,383.
- EDWIN C. REISZ (Chief Administrative Officer) has made 0 purchases and 6 sales selling 213,013 shares for an estimated $1,610,700.
- MATTHEW BUCKHALTER (Chief Financial Officer) has made 0 purchases and 6 sales selling 89,107 shares for an estimated $697,150.
- PATRICK A. CUNNINGHAM (Chief Compliance Officer) has made 0 purchases and 6 sales selling 85,175 shares for an estimated $655,556.
- DEBORAH STEWART (SVP, Chief Accounting Officer) has made 0 purchases and 6 sales selling 64,431 shares for an estimated $501,322.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
AVEANNA HEALTHCARE Hedge Fund Activity
We have seen 122 institutional investors add shares of AVEANNA HEALTHCARE stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LITTLEJOHN & CO LLC removed 3,140,105 shares (-52.9%) from their portfolio in Q4 2025, for an estimated $25,654,657
- SUMMIT PARTNERS L P removed 2,100,000 shares (-21.8%) from their portfolio in Q4 2025, for an estimated $17,157,000
- AUSTRALIANSUPER PTY LTD removed 1,774,837 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $14,500,418
- VANGUARD GROUP INC added 1,535,351 shares (+38.0%) to their portfolio in Q4 2025, for an estimated $12,543,817
- CITADEL ADVISORS LLC added 1,511,417 shares (+3938.3%) to their portfolio in Q4 2025, for an estimated $12,348,276
- KING STREET CAPITAL MANAGEMENT, L.P. removed 1,286,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,506,620
- WOODLINE PARTNERS LP added 1,050,277 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,580,763
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
AVEANNA HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $AVAH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 12/08/2025
To track analyst ratings and price targets for AVEANNA HEALTHCARE, check out Quiver Quantitative's $AVAH forecast page.
AVEANNA HEALTHCARE Price Targets
Multiple analysts have issued price targets for $AVAH recently. We have seen 5 analysts offer price targets for $AVAH in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- David Macdonald from Truist Securities set a target price of $8.0 on 04/13/2026
- Andrew Mok from Barclays set a target price of $9.5 on 03/25/2026
- Ben Hendrix from RBC Capital set a target price of $9.0 on 03/23/2026
- Sean Dodge from BMO Capital set a target price of $10.0 on 03/20/2026
- A.J. Rice from UBS set a target price of $10.0 on 01/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
